Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Holding KYMR?
Track your performance easily

Kymera Therapeutics (KYMR) Income Statement

203 Followers

Kymera Therapeutics Income Statement

Last quarter (Q3 2024), Kymera Therapeutics's total revenue was $3.74M, a decrease of -20.88% from the same quarter last year. In Q3, Kymera Therapeutics's net income was $-62.49M. See Kymera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 87.56M$ 78.59M$ 46.83M$ 72.83M$ 34.03M$ 2.93M
Cost of Revenue
------
Gross Profit
$ 87.56M$ 78.59M$ 46.83M$ 72.83M--
Operating Expense
$ 287.75M$ 244.12M$ -208.08M$ 173.36M$ 80.34M$ 45.14M
Operating Income
$ -200.19M$ -165.53M$ -161.26M$ -100.53M$ -46.30M$ -42.20M
Net Non Operating Interest Income Expense
$ -190.00K$ -18.57M$ 179.00K$ 158.00K$ 711.00K$ 959.00K
Other Income Expense
$ -27.79M$ -18.57M$ -6.45M$ -313.00K--
Pretax Income
$ -167.47M$ -146.96M$ -154.81M$ -100.22M$ -45.59M$ -41.25M
Tax Provision
$ -200.00K-----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -167.47M$ -146.96M$ -154.81M$ -100.22M$ -54.64M$ -41.25M
Basic EPS
$ -2.34$ -2.52$ -2.87$ -2.09$ -3.15$ -2.05
Diluted EPS
$ -2.34$ -2.52$ -2.87$ -2.09$ -3.15$ -2.05
Basic Average Shares
$ 278.48M$ 58.37M$ 53.93M$ 47.99M$ 17.35M$ 20.14M
Diluted Average Shares
$ 278.48M$ 58.37M$ 53.93M$ 47.99M$ 17.35M$ 20.14M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 287.75M$ 244.12M$ 208.08M$ 173.36M$ 80.34M$ 45.14M
Net Income From Continuing And Discontinued Operation
$ -167.47M$ -146.96M$ -154.81M$ -100.22M$ -45.59M$ -41.25M
Normalized Income
$ -118.07M$ -116.10M--$ -45.59M$ -41.25M
Interest Expense
----$ 115.00K$ 46.00K
EBIT
$ -167.28M$ -146.77M$ -154.99M$ -100.38M$ -45.48M$ -41.20M
EBITDA
$ -161.00M$ -143.20M$ -152.01M$ -97.98M$ -43.72M$ -40.38M
Currency in USD

Kymera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis